Case report: IL‑31 receptor blockade markedly reduced neuropathic pruritus and improved quality of life in a 52‑year‑old woman after standard therapies failed Scarring reflects replacement of normal dermis by fibroblast-driven,…
Read More
Efficient history, targeted exam, selective labs and clear shared‑decision plans let dermatologists deliver meaningful vitiligo care in time‑pressed visits In routine practice, non‑segmental vitiligo (NSV) visits can be both brief…
Read More
Case Report: Peristomal Pyoderma Gangrenosum After Colectomy — A Clinical Reminder for Dermatologists This JDD Case Report dives into how a 55‑year‑old woman developed rapidly progressive, painful cribriform ulcers with…
Read More
When One Target Isn’t Enough — Dual Therapy Clears Refractory ADW An adolescent with persistent, widespread atopic dermatitis failed topical therapy and dupilumab, then achieved only partial control on upadacitinib…
Read More
A Single‑Patient Signal That IL‑31 Blockade May Finally Tame The Relentless Itch Of Linear IgA Disease Linear IgA bullous dermatosis can be as much an itch disorder as a blistering…
Read More
Biofilms, Hard Nodules, and the Surprising Power of Hypochlorous Acid Most hyaluronic acid lumps after filler settle on their own, but a rare “delayed-onset” nodule can spell trouble—especially when it…
Read More
Uncovering Hidden Autoimmune Threats In Healed Zoster Sites Sometimes the skin that’s healed from herpes zoster can harbor an unexpected surprise. In two striking cases, patients developed new autoimmune eruptions—discoid…
Read More
